Evidence map›Paper›PMID 36186760›Full record

ArticleFrontiers in medicine2022

Low sensitivity of the COVID-19 antigen test (PANBIO™ COVID-19 Ag rapid test) to detect asymptomatic infections in health personnel of the National Institute of Respiratory Diseases.

Eduardo Becerril Vargas, Gabriel Cojuc-Konigsberg, Mario Alberto Mujica Sánchez, María Del Carmen García Colín, Daniel Alfredo Camacho Corral, Hugo Hansel Chávez Morales, José Nicolas Aguirre Pineda, Eduardo Martínez Bravo, Alejandro Ortiz Martínez, José Arturo Martínez Orozco and 5 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Eduardo Becerril VargasClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Gabriel Cojuc-KonigsbergClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Mario Alberto Mujica SánchezClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
María Del Carmen García ColínClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Daniel Alfredo Camacho CorralClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Hugo Hansel Chávez MoralesClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
José Nicolas Aguirre PinedaClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Eduardo Martínez BravoClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Alejandro Ortiz MartínezClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
José Arturo Martínez OrozcoClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Victor Manuel Rodríguez-SánchezClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Jesús Ariel Mariscal OchoaClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Brian Pantoja JiménezClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Israel A Morales LozadaClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.
Andrea Iraís Cuevas RodriguezClinical Microbiology Laboratory, National Institute of Respiratory Diseases, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 requires an early diagnosis to optimize management and limit transmission. SARS-CoV-2 is able to spread effectively. Infected asymptomatic individuals have been found to be contagious. RT-qPCR is the currently recommended laboratory method for diagnosing acute infection. However, rapid antigen detection (RAD) tests are not only fast, but require less specialized training. The possibility of using RAD tests to identify asymptomatic patients is attractive, as it could effectively contribute to minimizing the hospital spread of SARS-CoV-2. The objective of the study was to determine the performance of RAD vs. RT-qPCR for the detection of asymptomatic cases in INER health personnel. Methods: In order to follow WHO guidelines, generalized tests, a test station for health care workers was implemented on demand. A rapid test was carried out and a second sample was taken to be processed by RT-qPCR. With the results of both tests we conducted a retrospective study. Sensitivity, specificity, positive predictive value, negative predictive value and negative likelihood ratios were calculated. Results: A total of 1640 RAD tests were performed in health care workers (mean age was 39, 69, 47% with a self-reported comorbidity). Participants provided 1,640 valid RAD/RT-qPCR test pairs with 2% testing positive Conclusions: RADs are not recommended for the detection of asymptomatic cases due to low performance.

Indexed as

asymptomaticCOVID-19detectionPCRrapid antigen tests

Identifiers

PMID36186760
PMCPMC9524221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.